Medical and Pharmaceutical Inovio advances DNA medicine for debilitating respiratory condition The FDA acknowledged that the therapy could support a Biologics License Application under its accelerated approval program Joseph Morton4 days ago
Crypto/Blockchain 180 Life Sciences shares spike 76% on crypto company rebrand The company committed to building a substantial Ethereum treasury Joseph MortonAugust 12, 2025
Medical and Pharmaceutical Puma Biotechnology shares get favourable price bump on strong Q2 results The absence of negative developments over the past month has helped sentiment recover Joseph MortonAugust 11, 2025
Medical and Pharmaceutical Y-mAbs stock soars over 100% after acquisition deal with SERB S.A.S. The stock opened at USD$8.54 and traded as high as USD$8.59 before dipping briefly to USD$4.20 before ending the day at USD$8.52 Joseph MortonAugust 5, 2025
Medical and Pharmaceutical Lantern Pharma completes Japanese enrolment for lung cancer drug trial Japan has an extremely high rate of non-smokers getting diagnosed with the disease Rowan DunneAugust 5, 2025
Crypto/Blockchain Liminatus Pharma shares spike 26% on Digital Asset focused capital raise plans The engagement builds upon Liminatus’s previously announced review of a blockchain-integrated treasury strategy Joseph MortonJuly 24, 2025
Medical and Pharmaceutical Cizzle Bio submits NIH grant proposal for biomarker blood test for lung cancer The study will analyze pre-diagnostic and longitudinal blood plasma samples from the PLCO Cancer Screening Trial Joseph MortonJuly 14, 2025
Medical and Pharmaceutical Supernus Pharmaceuticals picks up embattled Sage Therapeutics Acquiring Sage expands Supernus’s presence in nonpsychiatric conditions Joseph MortonJune 16, 2025
Medical and Pharmaceutical QuidelOrtho seeks FDA approval to complete acquisition of LEX Diagnostics LEX Diagnostics develops molecular diagnostics to improve patient care by delivering clinical insights Joseph MortonJune 6, 2025
Medical and Pharmaceutical Phase Scientific International advances urine biopsy tech with $34M fundraising round The company has gained strong market traction by launching over 30 diagnostic products across multiple health categories Joseph MortonMay 26, 2025